Literature DB >> 25696921

G-protein-coupled receptor kinase 2-mediated desensitization of adiponectin receptor 1 in failing heart.

Yajing Wang1, Erhe Gao2, Wayne Bond Lau2, Yang Wang2, Gaizheng Liu2, Jing-Jing Li2, Xiaoliang Wang2, Yuexing Yuan2, Walter J Koch2, Xin-Liang Ma1.   

Abstract

BACKGROUND: Phosphorylative desensitization of G-protein-coupled receptors contributes significantly to post-myocardial infarction (MI) remodeling and heart failure (HF). Here, we determined whether adiponectin receptors (AdipoRs) 1 and 2 (the 7-transmembrane domain-containing receptors mediating adiponectin functions) are phosphorylatively modified and functionally impaired after MI. METHODS AND
RESULTS: Post-MI HF was induced by coronary artery occlusion. Receptor phosphorylation, kinase expression, and adiponectin function were determined via in vivo, ex vivo, and in vitro models. AdipoR1 and AdipoR2 are not phosphorylated in the normal heart. However, AdipoR1 was significantly phosphorylated after MI, peaking at 7 days and remaining significantly phosphorylated thereafter. The extent of post-MI AdipoR1 phosphorylation positively correlated with the expression level of GPCR kinase (GRK) 2, the predominant GRK isoform upregulated in the failing heart. Cardiac-specific GRK2 knockout virtually abolished post-MI AdipoR1 phosphorylation, whereas virus-mediated GRK2 overexpression significantly phosphorylated AdipoR1 and blocked adiponectin metabolic-regulatory/anti-inflammatory signaling. Mass spectrometry identified serine-7, threonine-24, and threonine-53 (residues located in the n-terminal intracellular AdipoR1 region) as the GRK2 phosphorylation sites. Ex vivo experiments demonstrated that adenosine monophosphate-activated protein kinase activation and the anti-tumor necrosis factor-α effect of adiponectin were significantly inhibited in cardiomyocytes isolated from nonischemic area 7 days after MI. In vivo experiments demonstrated that acute adiponectin administration-induced cardiac GLUT4 translocation and endothelial nitric oxide synthase phosphorylation were blunted 7 days after MI. Continuous adiponectin administration beginning 7 days after MI failed to protect the heart from adverse remodeling and HF progression. Finally, cardiac-specific GRK2 knockdown restored the cardioprotective effect of adiponectin.
CONCLUSION: AdipoR1 is phosphorylatively modified and desensitized by GRK2 in failing cardiomyocytes, contributing to post-MI remodeling and HF progression.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  adipokines; heart failure; phosphorylation; receptors, adiponectin

Mesh:

Substances:

Year:  2015        PMID: 25696921      PMCID: PMC4406820          DOI: 10.1161/CIRCULATIONAHA.114.015248

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  47 in total

1.  Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms.

Authors:  Rei Shibata; Kaori Sato; David R Pimentel; Yukihiro Takemura; Shinji Kihara; Koji Ohashi; Tohru Funahashi; Noriyuki Ouchi; Kenneth Walsh
Journal:  Nat Med       Date:  2005-09-11       Impact factor: 53.440

2.  APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function.

Authors:  Xuming Mao; Chintan K Kikani; Ramon A Riojas; Paul Langlais; Lixin Wang; Fresnida J Ramos; Qichen Fang; Christine Y Christ-Roberts; Jenny Y Hong; Ryang-Yeo Kim; Feng Liu; Lily Q Dong
Journal:  Nat Cell Biol       Date:  2006-04-16       Impact factor: 28.824

3.  Circulating adiponectin concentrations in patients with congestive heart failure.

Authors:  J George; S Patal; D Wexler; Y Sharabi; E Peleg; Y Kamari; E Grossman; D Sheps; G Keren; A Roth
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

Review 4.  Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.

Authors:  Takashi Kadowaki; Toshimasa Yamauchi; Naoto Kubota; Kazuo Hara; Kohjiro Ueki; Kazuyuki Tobe
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

5.  Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure.

Authors:  Wolfram Doehner; Mathias Rauchhaus; Piotr Ponikowski; Ian F Godsland; Stephan von Haehling; Darlington O Okonko; Francisco Leyva; Anthony J Proudler; Andrew J S Coats; Stefan D Anker
Journal:  J Am Coll Cardiol       Date:  2005-09-20       Impact factor: 24.094

6.  Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure.

Authors:  Tomohiro Nakamura; Hiroshi Funayama; Norifumi Kubo; Takanori Yasu; Masanobu Kawakami; Muneyasu Saito; Shin-ichi Momomura; San-E Ishikawa
Journal:  Circ J       Date:  2006-12       Impact factor: 2.993

Review 7.  Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease.

Authors:  D R Gable; S J Hurel; S E Humphries
Journal:  Atherosclerosis       Date:  2006-04-03       Impact factor: 5.162

8.  Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.

Authors:  Diane Gesty-Palmer; Minyong Chen; Eric Reiter; Seungkirl Ahn; Christopher D Nelson; Shuntai Wang; Allen E Eckhardt; Conrad L Cowan; Robert F Spurney; Louis M Luttrell; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2006-02-21       Impact factor: 5.157

9.  Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure.

Authors:  Guido Iaccarino; Emanuele Barbato; Ersilia Cipolletta; Vincenzo De Amicis; Kenneth B Margulies; Dario Leosco; Bruno Trimarco; Walter J Koch
Journal:  Eur Heart J       Date:  2005-07-29       Impact factor: 29.983

Review 10.  Adipokines and vascular disease in diabetes.

Authors:  Barry J Goldstein; Rosario Scalia
Journal:  Curr Diab Rep       Date:  2007-02       Impact factor: 5.430

View more
  19 in total

Review 1.  Cardiovascular Adiponectin Resistance: The Critical Role of Adiponectin Receptor Modification.

Authors:  Yajing Wang; Xin L Ma; Wayne Bond Lau
Journal:  Trends Endocrinol Metab       Date:  2017-05-01       Impact factor: 12.015

2.  Restoring diabetes-induced autophagic flux arrest in ischemic/reperfused heart by ADIPOR (adiponectin receptor) activation involves both AMPK-dependent and AMPK-independent signaling.

Authors:  Yajing Wang; Bin Liang; Wayne Bond Lau; Yunhui Du; Rui Guo; Zheyi Yan; Lu Gan; Wenjun Yan; Jianli Zhao; Erhe Gao; Walter Koch; Xin-Liang Ma
Journal:  Autophagy       Date:  2017-09-01       Impact factor: 16.016

3.  GRK4-mediated adiponectin receptor-1 phosphorylative desensitization as a novel mechanism of reduced renal sodium excretion in hypertension.

Authors:  Yan Zhang; Shaoxiong Wang; Hefei Huang; Andi Zeng; Yu Han; Cindy Zeng; Shuo Zheng; Hongmei Ren; Yajing Wang; Yu Huang; Pedro A Jose; Xin-Liang Ma; Chunyu Zeng; Ken Chen
Journal:  Clin Sci (Lond)       Date:  2020-09-30       Impact factor: 6.124

4.  SIRT6 suppresses mitochondrial defects and cell death via the NF-κB pathway in myocardial hypoxia/reoxygenation induced injury.

Authors:  Ming-Yue Cheng; You-Wei Cheng; Jun Yan; Xiao-Qin Hu; Hui Zhang; Zhi-Rong Wang; Qin Yin; Wei Cheng
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

5.  Targeting Adiponectin Receptor 1 Phosphorylation Against Ischemic Heart Failure.

Authors:  Di Zhu; Zhen Zhang; Jianli Zhao; Demin Liu; Lu Gan; Wayne Bond Lau; Dina Xie; Zhijun Meng; Peng Yao; Jumpei Tsukuda; Theodore A Christopher; Bernard L Lopez; Erhe Gao; Walter J Koch; Yajing Wang; Xin-Liang Ma
Journal:  Circ Res       Date:  2022-05-25       Impact factor: 23.213

6.  Adiponectin: Just Along for the Ride?

Authors:  Aslan T Turer; Philipp E Scherer
Journal:  Circ Res       Date:  2016-07-22       Impact factor: 17.367

7.  Alternative splicing variant of the scaffold protein APPL1 suppresses hepatic adiponectin signaling and function.

Authors:  Amanda K Galan-Davila; Jiyoon Ryu; Kun Dong; Yang Xiao; Zhe Dai; Deling Zhang; Zhi Li; Amanda M Dick; Kevin D Liu; Amrita Kamat; Min Lu; Qunfeng Dong; Feng Liu; Lily Q Dong
Journal:  J Biol Chem       Date:  2018-02-26       Impact factor: 5.157

8.  AdipoRon, an adiponectin receptor agonist, attenuates cardiac remodeling induced by pressure overload.

Authors:  Ning Zhang; Wen-Ying Wei; Hai-Han Liao; Zheng Yang; Can Hu; Sha-Sha Wang; Wei Deng; Qi-Zhu Tang
Journal:  J Mol Med (Berl)       Date:  2018-10-19       Impact factor: 4.599

9.  Inhibition of G-protein-coupled Receptor Kinase 2 Prevents the Dysfunctional Cardiac Substrate Metabolism in Fatty Acid Synthase Transgenic Mice.

Authors:  Joshua Abd Alla; Muriel Graemer; Xuebin Fu; Ursula Quitterer
Journal:  J Biol Chem       Date:  2015-12-15       Impact factor: 5.157

10.  Identification of Independent and Communal Differentially Expressed Genes as Well as Potential Therapeutic Targets in Ischemic Heart Failure and Non-Ischemic Heart Failure.

Authors:  Zuoxiang Wang; Mingyang Zhang; Yinan Xu; Yiyu Gu; Yumeng Song; Tingbo Jiang
Journal:  Pharmgenomics Pers Med       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.